BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30682135)

  • 1. Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles.
    Koeppen K; Barnaby R; Jackson AA; Gerber SA; Hogan DA; Stanton BA
    PLoS One; 2019; 14(1):e0211290. PubMed ID: 30682135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrins reduce the ability of Pseudomonas aeruginosa outer-membrane vesicles to reduce CFTR Cl
    Barnaby R; Koeppen K; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L206-L215. PubMed ID: 30358440
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
    bioRxiv; 2024 Feb; ():. PubMed ID: 38352468
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L574-L588. PubMed ID: 38440830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells.
    Stanton BA; Coutermarsh B; Barnaby R; Hogan D
    PLoS One; 2015; 10(5):e0127742. PubMed ID: 26018799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.
    Anderson GG; Moreau-Marquis S; Stanton BA; O'Toole GA
    Infect Immun; 2008 Apr; 76(4):1423-33. PubMed ID: 18212077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of
    Stanton BA
    Am J Physiol Cell Physiol; 2017 Apr; 312(4):C357-C366. PubMed ID: 28122735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
    Esoda CN; Kuehn MJ
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744920
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Saint-Criq V; Villeret B; Bastaert F; Kheir S; Hatton A; Cazes A; Xing Z; Sermet-Gaudelus I; Garcia-Verdugo I; Edelman A; Sallenave JM
    Thorax; 2018 Jan; 73(1):49-61. PubMed ID: 28790180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.
    Moreau-Marquis S; Bomberger JM; Anderson GG; Swiatecka-Urban A; Ye S; O'Toole GA; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L25-37. PubMed ID: 18359885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung.
    Ballok AE; O'Toole GA
    J Bacteriol; 2013 Sep; 195(18):4013-9. PubMed ID: 23836869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.
    Phennicie RT; Sullivan MJ; Singer JT; Yoder JA; Kim CH
    Infect Immun; 2010 Nov; 78(11):4542-50. PubMed ID: 20732993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
    Campodónico VL; Gadjeva M; Paradis-Bleau C; Uluer A; Pier GB
    Trends Mol Med; 2008 Mar; 14(3):120-33. PubMed ID: 18262467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
    Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G
    Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung.
    Hvorecny KL; Dolben E; Moreau-Marquis S; Hampton TH; Shabaneh TB; Flitter BA; Bahl CD; Bomberger JM; Levy BD; Stanton BA; Hogan DA; Madden DR
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L150-L156. PubMed ID: 28982736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa.
    Butterworth MB; Zhang L; Heidrich EM; Myerburg MM; Thibodeau PH
    J Biol Chem; 2012 Sep; 287(39):32556-65. PubMed ID: 22859302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system.
    Bomberger JM; Ye S; Maceachran DP; Koeppen K; Barnaby RL; O'Toole GA; Stanton BA
    PLoS Pathog; 2011 Mar; 7(3):e1001325. PubMed ID: 21455491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence.
    Scheid P; Kempster L; Griesenbach U; Davies JC; Dewar A; Weber PP; Colledge WH; Evans MJ; Geddes DM; Alton EW
    Eur Respir J; 2001 Jan; 17(1):27-35. PubMed ID: 11307750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.